Zixing Huang

Zixing Huang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
ZHZixing Huang
Zixing Huang
SZShuang Zhao
Shuang Zhao
ZLZhenlin Li
Zhenlin Li
WCWeixia Chen
Weixia Chen
LZLihong Zhao
Lihong Zhao
BSBin Song
Bin Song

1 July 2012 in European Journal of Radiology
Verified
Journal Article
Closed access
WYWen-Jie Yin
Wen-Jie Yin
FLFang Liu
Fang Liu
XLXiao-Mei Li
Xiao-Mei Li
LYLing Yang
Ling Yang
SZShuang Zhao
Shuang Zhao
RLRong-Bo Liu
Rong-Bo Liu

20 November 2017 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
XLXijiao Liu
Xijiao Liu
HJHanyu Jiang
Hanyu Jiang
JCJie Chen
Jie Chen
YZYou Zhou
You Zhou
ZHZixing Huang
Zixing Huang
BSBin Song
Bin Song

15 March 2019 in European Radiology
Verified
Journal Article
Closed access
PDF file
YWYi Wei
Yi Wei
ZHZixing Huang
Zixing Huang
HTHehan Tang
Hehan Tang
LDLiping Deng
Liping Deng
YYYuan Yuan
Yuan Yuan
BSBin Song
Bin Song

27 September 2016 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
HJHanyu Jiang
Hanyu Jiang
JCJie Chen
Jie Chen
RGRonghui Gao
Ronghui Gao
ZHZixing Huang
Zixing Huang
MWMingpeng Wu
Mingpeng Wu
BSBin Song
Bin Song

25 July 2019 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
SZShuang Zhao
Shuang Zhao
YWYing Wan
Ying Wan
ZHZixing Huang
Zixing Huang
BSBin Song
Bin Song
JYJian-qun Yu
Jian-qun Yu
Castleman disease (CD) is a group of uncommon lymphoproliferative disorders that is easily confused with lymphoma or other solid tumors. The purpose of our study was to evaluate the imaging and clinical findings of CD, and thus improve the understanding and diagnosis of CD. This retrospective study included 74 patients (37 men and 37 women, mean age ± standard deviation, 35 ± 15.2 years,) with histopathologically confirmed CD diagnosed based on CT or MRI between January 2010 and May 2017. The CT and MRI findings were analyzed by two radiologists in consensus, and clinical presentation and histopathologic characteristics were documented. The CD subtypes included 61 hyaline vascular variant cases (82.4%) and 13 plasma cell variant cases (17.6%). Unicentric CD and multicentric CD were observed in 65 (87.8%) and 9 (12.2%) patients, respectively. On non-enhanced CT, enlarged nodes with hypodensity or isodensity were seen, whereas varying degrees of enhancement were observed in contrast-enhanced CT. Homogeneous and heterogeneous enhancements were observed in 43 (62.3%) and 26 (37.7%) patients, respectively. Hypertrophied vessels and calcification were detected in 38 (51.2%) and 18 (24.3%) patients, respectively. MRI revealed hypointense to isointense lesions on T1-weighted images, isointense to hyperintense lesions on T2-weighted images, and hyperintense lesions on diffusion-weighted imaging; 9 (75%) and 3 (25%) patients demonstrated homogeneous and heterogeneous enhancement, respectively. CD often shows well-defined, mildly hypodense or isodense, homogeneous lymph nodules on non-enhanced CT/MRI, with intermediate and marked enhancement on contrast-enhanced CT/MRI. Calcification and hypertrophied vessels may be valuable diagnostic features.